ImageneBio, Inc.
ImageneBio, Inc. (IMA): 1 pipeline candidate · 1 upcoming catalyst · ~24 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
23.6 months
D/E 0.11
N/A
1 candidate
1 upcoming, next in ~196d
5 buys · 0 sells (180d)
A transparent, data-derived signal for ImageneBio, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$62.5M
Cash
$76.0M
Quarterly Burn
$14.8M
Runway
23.6 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| img-007 | — |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
35
Total value held
$18.8M
| Holder | Shares | Value |
|---|---|---|
| bvf inc/il | 1,110,002 | $5.6M |
| vanguard capital management llc | 650,310 | $3.3M |
| omega fund management, llc | 455,361 | $2.3M |
| orbimed advisors llc | 378,556 | $1.9M |
| rtw investments, lp | 334,445 | $1.7M |
| blackrock, inc. | 129,214 | $646K |
| citadel advisors llc | 124,345 | $622K |
| renaissance technologies llc | 81,696 | $408K |
| adage capital partners gp, l.l.c. | 66,666 | $333K |
| geode capital management, llc | 59,929 | $300K |
Showing top 10 of 35 institutional holders of ImageneBio, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in ImageneBio, Inc.'s pipeline?
ImageneBio, Inc. (IMA) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is ImageneBio, Inc.'s next catalyst?
ImageneBio, Inc.'s next tracked catalyst is a Phase2_Topline event — "Phase 2 Readout: img-007" — expected December 31, 2026.
What is ImageneBio, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ImageneBio, Inc. has approximately 23.6 months of cash runway.
What is ImageneBio, Inc.'s market capitalization?
ImageneBio, Inc.'s market capitalization is approximately $62.5M.
Who is the CEO of ImageneBio, Inc.?
Dr. Kristin Yarema Ph.D. is the chief executive officer of ImageneBio, Inc. (IMA).
Get the full picture on ImageneBio, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.